JYMMiN

What JYMMiN does

JYMMiN GmbH is a Leipzig-based HealthTech company and spin-off from the Max Planck Institute for Human Cognitive and Brain Sciences, founded by neuroscientist Prof. Dr. Thomas Fritz (inventor), Robert Gierke (former adidas manager), and Patrick Schaub (innovation management specialist). The company develops Jymmin, a clinically tested software solution that connects to rehabilitation equipment such as ergometers and strength machines and uses an AI-powered system to generate adaptive music in real time based on a patient's movements. The audio output is designed to stimulate the brain's emotional and motor systems, increasing patient motivation, reducing perceived pain during therapy, and reducing the need for one-on-one therapist supervision.

The product targets enterprise buyers in the healthcare sector — specifically rehabilitation clinics and therapy centers — with documented deployments and testimonials at NRZ Leipzig Rehabilitation Center. JYMMiN goes to market through a direct, consultative B2B enterprise sales motion, supported by a professional website, a contact-form-driven lead capture funnel, and LinkedIn presence of the founding team. The technology is licensed in from the Max Planck Institute, lending scientific credibility.

Revenue mechanics appear to be B2B software licensing to clinics, with ongoing subscription or licensing fees for access to the Jymmin adaptive music software integrated with rehabilitation equipment. The company operates with 1-10 employees and a single named customer reference as of the available data, with no disclosed revenue, funding, or institutional investors.

Name

JYMMiN

Legal name

JYMMiN GmbH

Website

https://jymmin.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

JYMMiN is a Leipzig-based HealthTech spin-off from the Max Planck Institute that sells AI-powered adaptive music software to rehabilitation clinics, turning patient movement during therapy into real-time music to boost motivation and reduce perceived pain.

Ownership category

akta.pro rank

Product category

Rehabilitation Software

NAICS

Software Publishers (5132)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

DTx/SaMD Deployment, Integration & Reimbursement Enablement (HLACANAO)

akta.pro secondary industry

AI Music Creation & Assistive Tools (Generation, Separation, Mastering) (MPAIAIAG)

Keywords

• Adaptive music software
• Rehabilitation technology
• AI music generation
• Movement-based therapy
• Clinical neurotechnology

Headquarters

HQ city

Leipzig

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Others

Revenue model

1. Software Licensing to Clinics: B2B software licensing model where clinics pay for access to the Jymmin adaptive music software. The software is provided as a clinical solution integrated with rehabilitation equipment, likely requiring ongoing subscription or licensing fees.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

JYMMiN develops and sells Jymmin, an AI-powered adaptive music software that connects to rehabilitation equipment such as ergometers and strength machines and generates real-time music based on patient movement. The product is licensed to rehabilitation clinics to increase patient motivation, reduce perceived pain, and reduce one-on-one therapist supervision time. It is based on neuroscience research at the Max Planck Institute for Human Cognitive and Brain Sciences.

Product overview

Jymmin is a single unified product — an adaptive music software solution for rehabilitation. The core Jymmin software links with rehabilitation equipment such as ergometers or strength machines, using AI to generate adaptive music in real time as patients move. The system is designed for clinical use in rehabilitation centers to boost patient motivation, reduce perceived pain, and save therapist time.

Differentiator

Problem solved

Functional benefit

Products and services

• Jymmin adaptive music software AI-powered adaptive music software that links with rehabilitation equipment such as ergometers and strength machines, transforming patient movement into real-time adaptive music to boost motivation, reduce perceived pain, and reduce therapist supervision time. Targeted at physical rehabilitation clinics and therapy centers.

Quantifiable outcome

• Patients stay engaged longer and move with more energy
• +2 more outcomes

Named customers2 records

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

Partnerships

One partnership is on record.

• Max Planck Institute for Human Cognitive and Brain SciencescoreStrategic or Co-development PartnerJYMMiN is a spin-off company originating from research conducted at the Max Planck Institute for Human Cognitive and Brain Sciences. Prof. Dr. Thomas Fritz, inventor of the Jymmin technology, developed the adaptive music technology during his tenure at the institute. This institutional relationship provides scientific credibility, ongoing research access, and a talent pipeline.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Emerging players

• Endel: AI-powered personalized soundscapes that adapt in real time to inputs such as movement, heart rate, and time of day. Comparable real-time adaptive music technology stack, though focused on consumer wellness and sleep.
• Brain.fm: AI-generated functional music designed to influence brain states such as focus, relaxation, and sleep. Comparable to JYMMiN's adaptive-music-from-AI approach, though positioned for consumer wellness rather than clinical rehab.
• Apollo Neuroscience: Developer of a wearable device that uses gentle vibrations to modulate stress, focus, and sleep via the nervous system. Comparable neuroscience-meets-consumer-health positioning and similar early-stage commercial profile.
• Mubert: Generative AI music platform producing royalty-free adaptive music for apps, games, and content. Comparable in core AI music-generation capability, though B2B-licensing oriented to media/tech rather than healthcare.
• AIVA: AI music composition assistant used by creators and developers. Comparable underlying generative AI for music technology, though not applied to clinical rehabilitation.
• SonoHealth: Music- and sound-based digital health intervention for stress, sleep, and cardiovascular outcomes. Comparable intersection of adaptive audio technology and clinical/wellness use cases, though earlier-stage and consumer-leaning.

Broad incumbents

• Akili Interactive: Listed digital therapeutics company with FDA-cleared software for cognitive conditions. Comparable as a prescription-style digital therapeutic in clinical channels, and a benchmark for what SaMD regulatory clearance and commercialization look like at scale.
• Click Therapeutics: Prescription digital therapeutics developer focused on underserved medical conditions, combining cognitive neuroscience with software. Comparable as a digital therapeutic company applying neuroscience science to clinical indications via software.
• Pear Therapeutics: Historically prominent prescription digital therapeutics company (PDTs) for substance use disorder, insomnia, and other conditions. Comparable as a regulated software-as-medical-device for a specific clinical use case, providing a relevant strategic reference even though the company has undergone restructuring.

Direct peers

• MedRhythms: US-based digital therapeutics company that uses rhythmic auditory stimulation and music-based interventions for neurologic injury rehabilitation. Most directly comparable to JYMMiN in combining neuroscience-backed music with rehab outcomes and pursuing SaMD positioning.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about JYMMiN